524322
KABRADG
Start SIP
Invest Now
Start SIP in KABRADG
Performance
- Low
- ₹28
- High
- ₹29
- 52 Week Low
- ₹10
- 52 Week High
- ₹33
- Open Price₹28
- Previous Close₹28
- Volume62,973
- 50 DMA₹26.71
- 100 DMA₹23.54
- 200 DMA₹19.00
Investment Returns
- Over 1 Month + 0.32%
- Over 3 Month + 69.09%
- Over 6 Month + 44.2%
- Over 1 Year + 184.39%
Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!
Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.8
- PEG Ratio
- 0.3
- Market Cap Cr
- 68
- P/B Ratio
- 2.6
- Average True Range
- 1.74
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.97
- RSI
- 50.79
- MFI
- 69.91
Kabra Drugs Financials
Kabra Drugs Technicals
EMA & SMA
Current Price
₹28.61
+
0.18
(0.63%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹28.91
- 50 Day
- ₹26.71
- 100 Day
- ₹23.54
- 200 Day
- ₹19.00
Resistance and Support
28.4
- R3 30.16
- R2 29.50
- R1 29.06
- S1 27.96
- S2 27.30
- S3 26.86
Kabra Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-28 | Others | Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion. |
| 2025-11-13 | Quarterly Results | |
| 2025-10-08 | Others | Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters. |
| 2025-09-02 | Others | Inter-alia, to consider 1. Directors Report and Corporate Governance Report for the financial year 2024 -25. 2. Draft Notice calling the AGM. 3. Other business matters. |
| 2025-08-14 | Quarterly Results |
Kabra Drugs F&O
About Kabra Drugs
- NSE Symbol
- KABRADG
- BSE Symbol
- 524322
- Managing Director
- Mr. N Aravind
- ISIN
- INE323K01017
Similar Stocks to Kabra Drugs
Kabra Drugs FAQs
Kabra Drugs share price is ₹28 As on 09 January, 2026 | 03:44
The Market Cap of Kabra Drugs is ₹67.8 Cr As on 09 January, 2026 | 03:44
The P/E ratio of Kabra Drugs is 56.8 As on 09 January, 2026 | 03:44
The PB ratio of Kabra Drugs is 2.6 As on 09 January, 2026 | 03:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.